Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 03, 2025
Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification.
Journal: Urology
Published: August 18, 2025
Patient awareness and perspectives regarding the value of focal therapy for localized prostate cancer: A cross-sectional study.
Journal: Urologic oncology
Published: June 30, 2025
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial.
Journal: The Lancet. Oncology
Published: February 05, 2025
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
Journal: The Journal of urology
Published: May 05, 2024
Case report: A novel somatic SDHB variant in a patient with bladder paraganglioma.
Journal: Frontiers in endocrinology
Published: February 14, 2024
Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 06, 2023
Micro-Ultrasound Guided Transperineal Prostate Biopsy: A Clinic-Based Procedure.
Journal: Journal of visualized experiments : JoVE
Published: February 22, 2023
Last Updated: 09/26/2026